8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)
Acumen Pharmaceuticals, Inc.（CIK 0001576885）于 2026-10-30 向 SEC 提交 8-K，报告日期为 2026-10-30，共 14 份文件。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 07:06:12
Documents
14
Period of Report
2026-10-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
Mailing Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465
Business Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 617-344-4190
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)
EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40551 | Film No.: 261504388
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov